The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Tools & Techniques
Tools & Techniques: Alcohol septal ablation for hypertrophic cardiomyopathy
Stefan C. Bertog1,2, MD, FACC, FSCAI; Jennifer Franke1, MD; Marius Hornung1, MD; Ilona Hofmann1, MD; Horst Sievert1*, MD, FACC, FSCAI, FESC
1. CardioVascular Center Frankfurt, Frankfurt, Germany; 2. Veterans Affairs Medical Center, Minneapolis, MN, USA
Hypertrophic cardiomyopathy (HCM) is a relatively common disorder with a prevalence of approximately one in five hundred. It is associated with an increased risk of arrhythmic sudden cardiac death and hea
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next article
A drug-eluting stent, accidentally removed as late as 1½ years after implantation